Free Trial

Stepan (NYSE:SCL) Issues Earnings Results, Beats Estimates By $0.06 EPS

Stepan logo with Basic Materials background
Image from MarketBeat Media, LLC.

Key Points

  • Stepan reported $0.45 EPS, beating estimates by $0.06, but revenue missed at $604.5M vs. ~$613M and the company posted a GAAP net loss of $41.4M, with adjusted net income and EBITDA down significantly year‑over‑year.
  • Management is pursuing Project Catalyst to deliver about $100 million in pre‑tax savings over two years, agreed to sell Millsdale land for $30M, and is focused on deleveraging with net debt of $511M and leverage near 2.7x while 2026 CapEx is guided to $105–115M.
  • The board declared a quarterly dividend of $0.395 (≈3.2% yield), but analyst sentiment has weakened with a consensus rating of "Sell" after recent downgrades.
  • MarketBeat previews the top five stocks to own by May 1st.

Stepan (NYSE:SCL - Get Free Report) posted its quarterly earnings results on Tuesday. The basic materials company reported $0.45 earnings per share for the quarter, topping the consensus estimate of $0.39 by $0.06, FiscalAI reports. Stepan had a return on equity of 3.38% and a net margin of 2.01%.The business had revenue of $604.51 million during the quarter, compared to the consensus estimate of $612.95 million. During the same period in the prior year, the company posted $0.84 EPS. The firm's revenue for the quarter was up 1.9% compared to the same quarter last year.

Here are the key takeaways from Stepan's conference call:

  • Reported a GAAP net loss of $41.4 million in Q1 2026 largely from a $65.4 million pre-tax restructuring charge; Adjusted Net Income fell to $10.3 million (down 47%) and Adjusted EBITDA was $49.6 million (down 14%).
  • Project Catalyst remains on track to deliver about $100 million in pre-tax savings over the next two years (≈60% expected in 2026), and the company agreed to sell non‑productive Millsdale land for $30 million to strengthen the balance sheet.
  • Surfactants showed organic net sales growth (+8%) and volume gains in crop productivity, oilfield and industrial cleaning, but Surfactants Adjusted EBITDA declined ~$7 million due to temporary lower absorption and production timing in Asia, a U.S. cold snap, Mexican competitive pressure, and elevated oleochemical costs — management expects partial recovery in future quarters.
  • Polymers delivered an 8% increase in Adjusted EBITDA driven by North American spray‑foam and phthalic anhydride demand despite an 11% sales decline and weak European construction; Specialty Products volumes rose 30% (MCT line) though EBITDA was slightly down on mix and raw‑material timing.
  • Q1 cash from operations was $17 million and Free Cash Flow was negative $14 million (seasonal working capital build); Q1 CapEx was $31 million with a 2026 CapEx range of $105–115 million, net debt $511 million and leverage of 2.7 as management focuses on deleveraging.

Stepan Stock Performance

Shares of SCL opened at $49.20 on Wednesday. Stepan has a 12-month low of $41.82 and a 12-month high of $68.00. The company has a current ratio of 1.29, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27. The firm has a market cap of $1.12 billion, a PE ratio of 24.00 and a beta of 1.01. The company's 50 day simple moving average is $50.69 and its 200-day simple moving average is $49.93.

Stepan Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 15th. Stockholders of record on Monday, June 1st will be issued a $0.395 dividend. This represents a $1.58 annualized dividend and a dividend yield of 3.2%. The ex-dividend date of this dividend is Monday, June 1st. Stepan's dividend payout ratio is presently 77.07%.

Analysts Set New Price Targets

A number of brokerages recently issued reports on SCL. Zacks Research downgraded Stepan from a "hold" rating to a "strong sell" rating in a research report on Wednesday, March 4th. Weiss Ratings cut shares of Stepan from a "hold (c-)" rating to a "sell (d+)" rating in a research report on Wednesday, March 4th. Two investment analysts have rated the stock with a Sell rating, Based on data from MarketBeat.com, the company has a consensus rating of "Sell".

Read Our Latest Analysis on SCL

Trending Headlines about Stepan

Here are the key news stories impacting Stepan this week:

  • Positive Sentiment: Board approved a quarterly cash dividend of $0.395 per share (annualized yield ~3.2%); ex-dividend/record dates set — supports income investors. Stepan Declares Quarterly Dividend
  • Positive Sentiment: Reported EPS of $0.45 beat the consensus by a penny, showing earnings slightly ahead of expectations on a per-share basis. Zacks: Stepan Beats Q1 Estimates
  • Neutral Sentiment: Company published full Q1 press release, slide deck and earnings-call transcript — useful for digging into segment performance, cost dynamics and management commentary. Slide Deck / Press Release Earnings Call Transcript
  • Negative Sentiment: Revenue missed Street expectations — $604.5M reported vs. ~$613M expected — indicating weaker demand or unfavorable mix versus forecasts. Investing.com: Revenue Miss
  • Negative Sentiment: Company posted a $41.4M net loss in Q1 versus $19.7M net income a year ago and EPS materially down from prior-year levels — a sharp deterioration that pressures valuation and investor sentiment. PR Newswire: Q1 Results
  • Negative Sentiment: Management said growth investments and cost/mix issues are weighing on earnings (growth push creating short-term earnings pressure), a message that likely amplified the sell-off. TipRanks: Growth Push vs Earnings Pressure

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. Geode Capital Management LLC boosted its stake in shares of Stepan by 0.4% in the fourth quarter. Geode Capital Management LLC now owns 514,401 shares of the basic materials company's stock valued at $24,362,000 after buying an additional 2,060 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its holdings in Stepan by 5.1% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 477,456 shares of the basic materials company's stock valued at $22,612,000 after acquiring an additional 23,097 shares during the period. Goldman Sachs Group Inc. boosted its position in shares of Stepan by 195.5% during the 4th quarter. Goldman Sachs Group Inc. now owns 299,970 shares of the basic materials company's stock worth $14,207,000 after purchasing an additional 198,457 shares in the last quarter. Russell Investments Group Ltd. grew its stake in shares of Stepan by 36.7% during the 4th quarter. Russell Investments Group Ltd. now owns 285,918 shares of the basic materials company's stock worth $13,541,000 after purchasing an additional 76,711 shares during the period. Finally, Invesco Ltd. grew its stake in shares of Stepan by 25.4% during the 4th quarter. Invesco Ltd. now owns 163,111 shares of the basic materials company's stock worth $7,725,000 after purchasing an additional 33,048 shares during the period. Institutional investors and hedge funds own 82.70% of the company's stock.

About Stepan

(Get Free Report)

Stepan Company is a global manufacturer of specialty and intermediate chemicals, primarily known for its development and production of surfactants and related specialty products. The company's portfolio includes a wide range of ingredients used to enhance the performance of consumer and industrial formulations, such as emulsifiers, foam control agents, odor control agents, antimicrobial products and performance additives. These products are integral components in cleaning solutions, personal care items, agrochemical formulations, coatings, oilfield treatments and polymer systems.

Serving a diverse set of end-markets, Stepan's offerings address both consumer-facing and industrial applications.

Recommended Stories

Earnings History for Stepan (NYSE:SCL)

Should You Invest $1,000 in Stepan Right Now?

Before you consider Stepan, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stepan wasn't on the list.

While Stepan currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines